<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>6549059</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">31161764</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">6549059</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.5853/jos.2018.02999</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="publisher-id">jos-2018-02999</article-id></all-ids><extracted-table><table-id>t1-jos-2018-02999</table-id><table-label>Table 1.</table-label><table-caption>Characteristics of the subjects</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="t1-jos-2018-02999" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Characteristics of the subjects</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" rowspan="2" colspan="1">Variable</th><th align="center" valign="middle" rowspan="2" colspan="1">VFD patients (n=32)</th><th align="center" valign="middle" rowspan="2" colspan="1">Healthy controls (n=15)</th><th align="center" valign="middle" colspan="2" rowspan="1">Group differences<hr/></th></tr><tr><th align="center" valign="middle" rowspan="1" colspan="1"><italic>P</italic></th><th align="center" valign="middle" rowspan="1" colspan="1">t score or X<sup>.2</sup></th></tr></thead><tbody><tr><td align="left" valign="top" rowspan="1" colspan="1">Age (yr)</td><td align="center" valign="top" rowspan="1" colspan="1">64.8±10.4</td><td align="center" valign="top" rowspan="1" colspan="1">62.0±5.5</td><td align="center" valign="top" rowspan="1" colspan="1">0.33</td><td align="center" valign="top" rowspan="1" colspan="1">0.98</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Male sex</td><td align="center" valign="top" rowspan="1" colspan="1">25 (78.1)</td><td align="center" valign="top" rowspan="1" colspan="1">7 (46.7)</td><td align="center" valign="top" rowspan="1" colspan="1">0.03</td><td align="center" valign="top" rowspan="1" colspan="1">4.65</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Infarct in the left hemisphere</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pattern of the visual field defect</td><td align="center" valign="top" rowspan="1" colspan="1">16 (50.0)</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Homonymous hemianopia</td><td align="center" valign="top" rowspan="1" colspan="1">25 (78.1)</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Quadrantanopia in the top field</td><td align="center" valign="top" rowspan="1" colspan="1">4 (12.5)</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Quadrantanopia in the bottom field</td><td align="center" valign="top" rowspan="1" colspan="1">3 (9.4)</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hypertension</td><td align="center" valign="top" rowspan="1" colspan="1">21 (65.6)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (20.0)</td><td align="center" valign="top" rowspan="1" colspan="1">&lt;0.01</td><td align="center" valign="top" rowspan="1" colspan="1">8.51</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Diabetes</td><td align="center" valign="top" rowspan="1" colspan="1">12 (37.5)</td><td align="center" valign="top" rowspan="1" colspan="1">3 (20.0)</td><td align="center" valign="top" rowspan="1" colspan="1">0.23</td><td align="center" valign="top" rowspan="1" colspan="1">1.44</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Hyperlipidemia</td><td align="center" valign="top" rowspan="1" colspan="1">12 (37.5)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (13.3)</td><td align="center" valign="top" rowspan="1" colspan="1">0.09</td><td align="center" valign="top" rowspan="1" colspan="1">2.85</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Current smoking</td><td align="center" valign="top" rowspan="1" colspan="1">13 (40.6)</td><td align="center" valign="top" rowspan="1" colspan="1">2 (13.3)</td><td align="center" valign="top" rowspan="1" colspan="1">0.06</td><td align="center" valign="top" rowspan="1" colspan="1">3.50</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cardioembolic source</td><td align="center" valign="top" rowspan="1" colspan="1">5 (15.6)</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Follow-up from onset (day)</td><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/><td align="center" valign="top" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> Within 1 week</td><td align="center" valign="top" rowspan="1" colspan="1">3.5±2.0</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> At 1 month</td><td align="center" valign="top" rowspan="1" colspan="1">36.9±5.4</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> At 3 months</td><td align="center" valign="top" rowspan="1" colspan="1">97.7±11.3</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1"> At 6 months</td><td align="center" valign="top" rowspan="1" colspan="1">191.3±20.4</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td><td align="center" valign="top" rowspan="1" colspan="1">-</td></tr></tbody></table><table-wrap-foot><fn><p>Values are presented as mean±standard deviation or number (%). A two-sample t-test (t) or chi-square t-test (X<sup>2</sup>) was used for statistical analysis.</p><p>VFD, visual field defect.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1.<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Characteristics of the subjects</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="middle" rowspan="2">Variable</th><th align="center" valign="middle" rowspan="2">VFD patients (n=32)</th><th align="center" valign="middle" rowspan="2">Healthy controls (n=15)</th><th align="center" valign="middle" colspan="2">Group differences</th></tr><tr><th align="center" valign="middle">P</th><th align="center" valign="middle">t score or X.2</th></tr></thead><tbody><tr><td align="left" valign="top">Age (yr)</td><td align="center" valign="top">64.8±10.4</td><td align="center" valign="top">62.0±5.5</td><td align="center" valign="top">0.33</td><td align="center" valign="top">0.98</td></tr><tr><td align="left" valign="top">Male sex</td><td align="center" valign="top">25 (78.1)</td><td align="center" valign="top">7 (46.7)</td><td align="center" valign="top">0.03</td><td align="center" valign="top">4.65</td></tr><tr><td align="left" valign="top">Infarct in the left hemisphere</td><td align="center" valign="top"/><td align="center" valign="top"/><td align="center" valign="top"/><td align="center" valign="top"/></tr><tr><td align="left" valign="top">Pattern of the visual field defect</td><td align="center" valign="top">16 (50.0)</td><td align="center" valign="top">-</td><td align="center" valign="top">-</td><td align="center" valign="top">-</td></tr><tr><td align="left" valign="top"> Homonymous hemianopia</td><td align="center" valign="top">25 (78.1)</td><td align="center" valign="top">-</td><td align="center" valign="top">-</td><td align="center" valign="top">-</td></tr><tr><td align="left" valign="top"> Quadrantanopia in the top field</td><td align="center" valign="top">4 (12.5)</td><td align="center" valign="top">-</td><td align="center" valign="top">-</td><td align="center" valign="top">-</td></tr><tr><td align="left" valign="top"> Quadrantanopia in the bottom field</td><td align="center" valign="top">3 (9.4)</td><td align="center" valign="top">-</td><td align="center" valign="top">-</td><td align="center" valign="top">-</td></tr><tr><td align="left" valign="top">Hypertension</td><td align="center" valign="top">21 (65.6)</td><td align="center" valign="top">3 (20.0)</td><td align="center" valign="top">&lt;0.01</td><td align="center" valign="top">8.51</td></tr><tr><td align="left" valign="top">Diabetes</td><td align="center" valign="top">12 (37.5)</td><td align="center" valign="top">3 (20.0)</td><td align="center" valign="top">0.23</td><td align="center" valign="top">1.44</td></tr><tr><td align="left" valign="top">Hyperlipidemia</td><td align="center" valign="top">12 (37.5)</td><td align="center" valign="top">2 (13.3)</td><td align="center" valign="top">0.09</td><td align="center" valign="top">2.85</td></tr><tr><td align="left" valign="top">Current smoking</td><td align="center" valign="top">13 (40.6)</td><td align="center" valign="top">2 (13.3)</td><td align="center" valign="top">0.06</td><td align="center" valign="top">3.50</td></tr><tr><td align="left" valign="top">Cardioembolic source</td><td align="center" valign="top">5 (15.6)</td><td align="center" valign="top">-</td><td align="center" valign="top">-</td><td align="center" valign="top">-</td></tr><tr><td align="left" valign="top">Follow-up from onset (day)</td><td align="center" valign="top"/><td align="center" valign="top"/><td align="center" valign="top"/><td align="center" valign="top"/></tr><tr><td align="left" valign="top"> Within 1 week</td><td align="center" valign="top">3.5±2.0</td><td align="center" valign="top">-</td><td align="center" valign="top">-</td><td align="center" valign="top">-</td></tr><tr><td align="left" valign="top"> At 1 month</td><td align="center" valign="top">36.9±5.4</td><td align="center" valign="top">-</td><td align="center" valign="top">-</td><td align="center" valign="top">-</td></tr><tr><td align="left" valign="top"> At 3 months</td><td align="center" valign="top">97.7±11.3</td><td align="center" valign="top">-</td><td align="center" valign="top">-</td><td align="center" valign="top">-</td></tr><tr><td align="left" valign="top"> At 6 months</td><td align="center" valign="top">191.3±20.4</td><td align="center" valign="top">-</td><td align="center" valign="top">-</td><td align="center" valign="top">-</td></tr></tbody></table></div>Values are presented as mean±standard deviation or number (%). A two-sample t-test (t) or chi-square t-test (X2) was used for statistical analysis.VFD, visual field defect.</transformed-table></extracted-table></extracted-tables-set>